Literature DB >> 23343698

Extramammary Paget disease: epidemiology and association to cancer in a Quebec-based population.

Deana Funaro1, Mark Krasny, Christina Lam, Delphine Desy, Philippe Sauthier, Danielle Bouffard.   

Abstract

OBJECTIVE: This study aimed to further characterize the epidemiology, clinical manifestations, pathology, immunopathology, outcome from therapy, and associated underlying malignancy in extramammary Paget disease (EMPD).
MATERIALS AND METHODS: We conducted a retrospective review of patients treated for EMPD in our tertiary care center during a 23-year period ranging from 1985 to 2008.
RESULTS: Sixty-four cases of EMPD were diagnosed during this period. Mean age at diagnosis was 66.8 years. Of the patients, 79.7% were female. Tumors were mostly localized on the vulvoperineal region. Associated cancers were found in 30% of the patients and included breast cancer and urogenital cancers. Of the patients, 42% had a least 1 recurrence. The risk of recurrence could only be associated to tumor location on the vulvoperineal region. The limitations of this study include its retrospective nature and sample size.
CONCLUSIONS: Extramammary Paget disease is more commonly found on the vulva of older women and frequently recurs. Recurrence was not associated to margin status, which would support a more conservative therapeutic approach.

Entities:  

Mesh:

Year:  2013        PMID: 23343698     DOI: 10.1097/LGT.0b013e31825f4b4f

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  7 in total

1.  Clinical and pathological characteristics of extramammary Paget's disease: report of 246 Chinese male patients.

Authors:  Zhihua Kang; Qiaoan Zhang; Qunfeng Zhang; Xiangyu Li; Tingting Hu; Xiao Xu; Zhiyuan Wu; Xinju Zhang; Hua Wang; Jinhua Xu; Feng Xu; Ming Guan
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Diagnosis, Therapy and Follow-up Care of Vulvar Cancer and its Precursors. Guideline of the DGGG and DKG (S2k-Level, AWMF Registry Number 015/059, November 2015.

Authors:  H G Schnürch; S Ackermann; C D Alt; J Barinoff; C Böing; C Dannecker; F Gieseking; A Günthert; P Hantschmann; L C Horn; R Kürzl; P Mallmann; S Marnitz; G Mehlhorn; C C Hack; M C Koch; U Torsten; W Weikel; L Wölber; M Hampl
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-10       Impact factor: 2.915

3.  High Risk of Proximal and Local Neoplasms in 2206 Patients With Anogenital Extramammary Paget's Disease.

Authors:  Grace C Lee; Hiroko Kunitake; Caitlin Stafford; Liliana G Bordeianou; Todd D Francone; Rocco Ricciardi
Journal:  Dis Colon Rectum       Date:  2019-11       Impact factor: 4.585

Review 4.  Surgical Treatment for Extramammary Paget's Disease.

Authors:  Uwe Wollina; Alberto Goldman; Andrzej Bieneck; Mohamed Badawy Abdel-Naser; Sven Petersen
Journal:  Curr Treat Options Oncol       Date:  2018-05-03

5.  The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget Disease.

Authors:  Michelle van der Linden; Kim Meeuwis; Colette van Hees; Eleonora van Dorst; Johan Bulten; Tjalling Bosse; Joanna IntHout; Dorry Boll; Brigitte Slangen; Manon van Seters; Marc van Beurden; Mariëtte van Poelgeest; Joanne de Hullu
Journal:  JMIR Res Protoc       Date:  2017-09-06

6.  NECTIN4 Expression in Extramammary Paget's Disease: Implication of a New Therapeutic Target.

Authors:  Maho Murata; Takamichi Ito; Yuka Tanaka; Yumiko Kaku-Ito; Masutaka Furue
Journal:  Int J Mol Sci       Date:  2020-08-16       Impact factor: 5.923

7.  Mucosal Invasion, but Not Incomplete Excision, Has Negative Impact on Long-Term Survival in Patients With Extramammary Paget's Disease.

Authors:  Hiroki Hashimoto; Yumiko Kaku-Ito; Masutaka Furue; Takamichi Ito
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.